#+TITLE: Sphingolipid Degradation: Fabry
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today

* Introduction
- AKA: angiokeratoma corporis diffusum universale
- second most common LSD
- defect in *\alpha-galactosidase A (AKA: ceramide trihexosidase)*
  - cleaves terminal galactose from globotriaosylceramide (Gb3)
    (Figure [[fig:sidase]])
  - accumulation of Gb3 in blood vessels and other tissues
  - globotriaosylceramide (Gb3): the Fabry lipid (Figure [[fig:galac]])
  - 3 to 20% activity in hemizygote males
  - wide range of symptoms including kidney, heart, and skin symptoms
  - \uparrow Gb3 in kidney and blood group B antigenic glycosphingolipid
- \alpha-galactosidase A uses both sortilin and mannose receptor
  - not affected in ML II & III

#+CAPTION[Globotriaosylceramide]:  Globotriaosylceramide (Gb3): the Fabry lipid
#+NAME: fig:galac 
#+ATTR_LaTeX: :width 0.3\textwidth
[[file:./fabry/figures/globotriaosylceramide.png]]

#+CAPTION[\alpha-galactosidase A]:\alpha-galactosidase A, located in the lumen of lysosomes
#+NAME: fig:sidase
#+ATTR_LaTeX: :width 0.4\textwidth
[[file:./fabry/figures/galactosidaseA.png]]

* Genetics
- *XL GLA*
- penetrance in female heterozygotes
  - may be considered X-linked dominant

* Clinical Findings
- see table [[tab:fabss]]
- postprandial pain or diarrhea
  - may be sole complaint
- degradation of interphalangeal joints
- cerebrovascular - stroke, seizures
- ocular lesions
- angiokeratomas (Figure [[fig:skin]])
  - prominent on hip, buttocks and scrotum

#+CAPTION[]:Fabry Signs and Symptoms
#+NAME: tab:fabss
| Age         | Signs                                           |
|-------------+-------------------------------------------------|
| childhood   | pain in extremities, fever, Fabry crisis [fn:1] |
| adolescence | angiokeratomas                                  |
| adulthood   | CNS, myocardial and pulmonary                   |
| middle age  | renal failure, lymphedema                       |

[fn:1] induced by heat, cold, fatigue or emotional stress

#+CAPTION[Angiokeratomas of the skin]:Angiokeratomas of the Skin
#+NAME: fig:skin
#+ATTR_LaTeX: :width 0.6\textwidth
[[file:./fabry/figures/angiokeratomas.png]]

* Laboratory Investigations
** Biochemistry
- deficient \alpha-galactosidase A activity in leukocytes
  - fluorometric 4MU-\alpha-D-galactopyranoside substrate
  - LC-MS/MS
  - unreliable in females
- \uparrow urine Gb3 and Gb2 LC-MSMS 
  - hemizygote males and heterozygote females
- \uparrow plasma lyso-Gb3 (globotriaosylsphingosine) LC-MSMS
  - sensitive biomarker
  - useful in diagnosis and monitoring

** Pathology
- widespread deposition of Gb3
- vacuoles seen in variety of cells, \uparrow endothelium of blood vessels

#+CAPTION[Fabry EM]:EM showing concentric or lamellar structure of lysosomal inclusions in Fabry disease renal biopsy
#+NAME: fig:biopsy
#+ATTR_LaTeX: :width 0.4\textwidth
[[file:./fabry/figures/Fabrys-disease.jpg]]

* Treatment
- alleviate pain
  - chronic low dose of diphenylhydantoin
  - carbamazapine, gabapentin
- dialysis or renal transplantation
- there is long term experience with ERT
  - agalsidase (alpha or beta)
  - reduces left ventricular hypertrophy
  - less effect on renal function
  - does not prevent progression
- oral chaperone therapy - migalastat
  - only for amenable mutations


